Healthcare & Medical Devices Global On demand · 24-48h

Global Prefilled Syringe Barrels Market Strategic Research Report

Global Prefilled Syringe Barrels Market Strategic Research R…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Prefilled Syringe Barrels Market
$6.22B2025
2.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Glass Material, Plastic Material

By Application: Vaccines, Antithrombotic Drugs, Bioengineering Drugs, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: BD, Gerresheimer, Nipro Corporation, Schott, Stevanato, Baxter BioPharma Solution, Rovi CM, Terumo, Vetter, Catalent, Taisei Kako, Roselabs Group, West Pharma, Weigao Holding Company Limited, Shandong Linaer Group, Shandong Pharmaceutical Glass co., LTD, Ningbo Zhengli Pharmaceutical Packaging

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 131 pages
Market size 2025
$6.22B
Billion USD
Forecast CAGR
2.5%
2025-2032
Forecast 2032
$7.4B
Projected
Régions
5
Asia Pacific · Latin America · MEA · Europe · North America

Vue d'ensemble

Scope of the Report

The global Prefilled Syringe Barrels market size is predicted to grow from US$ 6,224 million in 2025 to US$ 7,404 million in 2032; it is expected to grow at a CAGR of 2.5% from 2026 to 2032.

Prefilled syringe, also known as prefilled syringe, prefilled syringe, prefillable syringe or PFS, integrates "drug storage" and "injection function". It is a high-tech, practical and new type of new dosage form of injection, which is mainly used in the fields of vaccines and non final sterilization biological agents. Prefilled syringe barrel is the focus of PFS technology and cost, accounting for more than 90% of the cost of prefilled syringes. It is made by syringe molding equipment.

Global Prefilled Syringe Barrels key players include BD, Gerresheimer, Weigao Holding Company Limited, etc. Global top three manufacturers hold a share over 55%. North America is the largest market, with a share about 35%, followed by China and Europe, both have a share about 40 percent. In terms of product, Glass Material is the largest segment, with a share over 80%. And in terms of application, the largest application is Vaccines, followed by Antithrombotic Drugs, Bioengineering Drugs, etc.

From the perspective of product type and technology, glass material is the most important application type, accounting for 83.6% of the global prefilled syringe and syringe production market in 2023. This proportion is even more prominent in China, where glass material accounts for 93.7% of China's prefilled syringe and syringe production market share.

From the perspective of product market application, the downstream industries of prefilled syringes and syringes are vaccines, antithrombotic drugs, bioengineering drugs, etc. In recent years, with the recovery of the global economy and the increasing attention paid to the medical and health field by developing countries and regions, the consumption of prefilled syringes and syringes has increased significantly. In the foreseeable future, the prefilled syringe market will show an optimistic upward trend.

This report presents a comprehensive overview of the global Prefilled Syringe Barrels market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Material

  • Glass Material
  • Plastic Material

Segment by Application

  • Vaccines
  • Antithrombotic Drugs
  • Bioengineering Drugs
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Prefilled Syringe Barrels market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Vaccines, Antithrombotic Drugs, Bioengineering Drugs evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Prefilled Syringe Barrels Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 2.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$6.22B
2025
Forecast
$7.4B
2032
CAGR
2.5%
2025–2032
Régions
5
global
Key companies
BDGerresheimerNipro CorporationSchottStevanatoBaxter BioPharma SolutionRovi CMTerumo
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Glass MaterialPlastic Material
By Application
VaccinesAntithrombotic DrugsBioengineering DrugsOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Glass Material
  • 3.1.3 Plastic Material
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Vaccines
  • 4.1.3 Antithrombotic Drugs
  • 4.1.4 Bioengineering Drugs
  • 4.1.5 Others
  • 4.1.6 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 BD
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Gerresheimer
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Nipro Corporation
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Schott
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Stevanato
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Baxter BioPharma Solution
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Rovi CM
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Terumo
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Vetter
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Catalent
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Taisei Kako
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Roselabs Group
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 West Pharma
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Weigao Holding Company Limited
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Shandong Linaer Group
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Shandong Pharmaceutical Glass co., LTD
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Ningbo Zhengli Pharmaceutical Packaging
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Prefilled Syringe Barrels market?
The global Prefilled Syringe Barrels market is estimated at US$ 6.22 billion in 2025 (base year) and is projected to reach US$ 7.4 billion by 2032.
What is the forecast CAGR for the Prefilled Syringe Barrels market?
The market is expected to grow at a CAGR of 2.5% from 2026 to 2032, expanding from US$ 6.22 billion in 2025 to US$ 7.4 billion in 2032, roughly 1.2 times its base-year value.
What is Prefilled Syringe Barrels?
Prefilled syringe, also known as prefilled syringe, prefilled syringe, prefillable syringe or PFS, integrates "drug storage" and "injection function". It is a high-tech, practical and new type of new dosage form of injection, which is mainly used in the fields of vaccines and non final sterilization biological agents. Prefilled syringe barrel is the focus of PFS technology and cost, accounting for more than 90% of the cost of prefilled syringes.
What are the main segments of the Prefilled Syringe Barrels market by material?
By material, the market is segmented into Glass Material and Plastic Material.
Which applications drive demand in the Prefilled Syringe Barrels market?
Key applications covered include Vaccines, Antithrombotic Drugs, Bioengineering Drugs and Others.
Who are the key players in the Prefilled Syringe Barrels market?
Key players profiled include BD, Gerresheimer, Nipro Corporation, Schott, Stevanato, Baxter BioPharma Solution, Rovi CM and Terumo, among 17 companies covered in total.
Which regions and countries are covered for Prefilled Syringe Barrels?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
Who should buy the Prefilled Syringe Barrels market report?
The report is intended for manufacturers and solution providers, distributors and end users in Vaccines, Antithrombotic Drugs and Bioengineering Drugs, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Prefilled Syringe Barrels market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3 500,00 $US
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.